Sen. Elizabeth Warren (D-Mass.) and Rep. Jan Schakowsky (D-Ill.) have introduced legislation that would require ...

Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating ...

In a perspective article published in Science, Professor Jonathan Rivnay explores next-generation bioelectronic medication.

Cannabis cultivation in the Netherlands is declining as more and more countries allow the cultivation of the soft drug, the ...

This story is part of "Out of Stock: Investigating America's Drug Shortage Crisis," a series exploring the causes and possible solutions of a problem plaguing America's health care system. The sudden ...

A CNBC investigation into illegal weight loss drugs reveals a marketplace where criminals brazenly counterfeit the drugs or ship the real product from overseas.

Justice secretary Shabana Mahmood is facing pressure from the public to link early releases from prison to drug testing, a new poll suggests. Polling of 2,001 adults conducted by Opinion Matters ...

Current treatments target one or the other of these hotspots, but the new drug uniquely targets and blocks both. The new study is a promising ‘first’ in Alzheimer’s drug development (PA ...

Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town A new drug to prevent HIV infection ...

Here, we analyse trends in the new drugs reviewed and approved by the PMDA and Ministry of Health, Labour and Welfare (MHLW) in the 20 years from FY2004. From FY2004 to FY2023, the PMDA and the ...

On Wednesday, Eli Lilly And Co. (NYSE:LLY) announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. As the company ...

The FDA has approved the first new class of schizophrenia drug in 70 years Australian science contributed to the discovery of the game-changing drug Schizophrenia is a hard-to-treat and common ...